Report: Corporate venture capital is catalyzing groundbreaking biomedical innovation in the United States

Venture capital is increasingly becoming the growing force for financing biotech and other startups, fueling medical advances in the U.S. A new report released today from TEConomy, examines the role and impact of one specific player in that ecosystem: biopharmaceutical corporate venture capital (CVC) funds, which often support early stage medical innovation.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Research and Development Source Type: news